4//SEC Filing
CROSS HERB 4
Accession 0001213900-25-051724
CIK 0001788028other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 6:25 AM ET
Size
5.7 KB
Accession
0001213900-25-051724
Insider Transaction Report
Form 4
CROSS HERB
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-04+90,000→ 90,000 totalExercise: $6.00Exp: 2035-06-04→ Voting Common Stock (90,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001230721
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 6:25 AM ET
- Size
- 5.7 KB